Hypoalbuminemia Is a Hepatocellular Carcinoma Independent Risk Factor for Tumor Progression in Low-Risk Bridge to Transplant Candidates
Due to active hepatocellular carcinoma (HCC) surveillance, many patients are diagnosed with early-stage disease and are usually amendable to curative treatments. These patients lack poor prognostic factors associated with Milan Criteria and alpha fetoprotein (AFP) biomarker levels. There are current...
Main Authors: | Kelley G. Núñez, Tyler Sandow, Jai Patel, Mina Hibino, Daniel Fort, Ari J. Cohen, Paul Thevenot |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-03-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/14/7/1684 |
Similar Items
-
Imaging Delay Following Liver-Directed Therapy Increases Progression Risk in Early- to Intermediate-Stage Hepatocellular Carcinoma
by: Jordin Stanneart, et al.
Published: (2024-01-01) -
Baseline Alpha-Fetoprotein, Alpha-Fetoprotein-L3, and Des-Gamma-Carboxy Prothrombin Biomarker Status in Bridge to Liver Transplant Outcomes for Hepatocellular Carcinoma
by: Kelley G. Núñez, et al.
Published: (2021-09-01) -
Distinct Gene Expression Profiles in Viable Hepatocellular Carcinoma Treated With Liver-Directed Therapy
by: Kelley G. Núñez, et al.
Published: (2022-06-01) -
Exosome Shedding Is Concordant with Objective Treatment Response Rate and Stratifies Time to Progression in Treatment Naïve, Non-Resectable Hepatocellular Carcinoma
by: Kelley G. Núñez, et al.
Published: (2023-12-01) -
Serum sphingosine negatively correlates with albumin predicting the risk of hepatocellular carcinoma
by: Kai Huang, et al.
Published: (2020-06-01)